Language:English
Language:

Xcessbio

Place your promotion here

You have no items in your shopping cart.

MSAB, β-catenin Inhibitor

MSAB, β-catenin Inhibitor

$129.00
A potent and selective Wnt/β-catenin inhibitor identified using cell-based chemical screening.
Catalog No. Unit Price Qty
M60316-2s 2 mg solid $129.00

Details

Product Information
Molecular Weight: 305.35
Formula: C15H15NO4S
Purity: ≥98%
CAS#: n/a
Solubility: DMSO up to 100 mM
Chemical Name: methyl 3-((4-methylphenyl)sulfonamido)benzoate
Storage: Powder: 4oC 1 year. DMSO: 4oC 3 month; -20oC 1 year.

Biological Activity:

MSAB is a potent and selective Wnt/β-catenin inhibitor identified using cell-based chemical screening. It binds to β-catenin, promoting its degradation, and specifically downregulates Wnt/β-catenin target genes. MSAB shows potent anti-tumor effects selectively on Wnt-dependent cancer cells in vitro and in mouse cancer models.

How to Use:

In vitro: MSAB was suggested to be used at 5-10 µM final concentration in vitro.
In vivo: MSAB was used to dose mice at 10-20 mg/kg by intraperitoneal injection once per day in xenograft model of HCT116, HCT115 and H23 cell lines, and MMTV-Wnt1 transgenic mice.

Reference:

  • 1. Hwang SY, et al. Direct Targeting of β-Catenin by a Small Molecule Stimulates Proteasomal Degradation and Suppresses Oncogenic Wnt/β-Catenin Signaling. (2016) Cell Rep. 16(1):28-36. 


MSAB_spec.pdf      
MSAB_MSDS.pdf      


Products are for research use only. Not for human use.

Description

Details

Product Information
Molecular Weight: 305.35
Formula: C15H15NO4S
Purity: ≥98%
CAS#: n/a
Solubility: DMSO up to 100 mM
Chemical Name: methyl 3-((4-methylphenyl)sulfonamido)benzoate
Storage: Powder: 4oC 1 year. DMSO: 4oC 3 month; -20oC 1 year.

Biological Activity:

MSAB is a potent and selective Wnt/β-catenin inhibitor identified using cell-based chemical screening. It binds to β-catenin, promoting its degradation, and specifically downregulates Wnt/β-catenin target genes. MSAB shows potent anti-tumor effects selectively on Wnt-dependent cancer cells in vitro and in mouse cancer models.

How to Use:

In vitro: MSAB was suggested to be used at 5-10 µM final concentration in vitro.
In vivo: MSAB was used to dose mice at 10-20 mg/kg by intraperitoneal injection once per day in xenograft model of HCT116, HCT115 and H23 cell lines, and MMTV-Wnt1 transgenic mice.

Reference:

  • 1. Hwang SY, et al. Direct Targeting of β-Catenin by a Small Molecule Stimulates Proteasomal Degradation and Suppresses Oncogenic Wnt/β-Catenin Signaling. (2016) Cell Rep. 16(1):28-36. 


MSAB_spec.pdf      
MSAB_MSDS.pdf      


Products are for research use only. Not for human use.

Reviews

Write Your Review

How do you rate this product? *

Price:
Value:
Quality: